Biomerica, Inc. (BMRA) financial statements (2021 and earlier)

Company profile

Business Address 17571 VON KARMAN AVENUE
IRVINE, CA 92614
State of Incorp. DE
Fiscal Year End May 31
SIC 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

11/30/2020
TTM
5/31/2020
5/31/2019
5/31/2018
5/31/2017
5/31/2016
5/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5,6848,6416871,2051,2251,8891,088
Cash and cash equivalents5,6848,6416871,2051,2251,8891,088
Receivables1,6121,7661,4558001,0609691,112
Inventory, net of allowances, customer advances and progress billings4,1982,8512,1512,1791,7291,8632,027
Inventory4,1982,8512,1512,1791,7291,8632,027
Deferred tax assets    74
Other undisclosed current assets4531,509202300196114164
Total current assets:11,94714,7674,4954,4844,2104,8354,466
Noncurrent Assets
Operating lease, right-of-use asset1,5961,712
Property, plant and equipment288279351351332381445
Intangible assets, net (including goodwill)21816910799174249321
Intangible assets, net (excluding goodwill)21816910799174249321
Other noncurrent assets262168127113955657
Deferred tax assets, net 104141670
Other undisclosed noncurrent assets165165165165165165165
Total noncurrent assets:2,5312,4937507398088911,659
TOTAL ASSETS:14,47817,2605,2455,2235,0185,7276,124
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,2589871,038687352333392
Employee-related liabilities392279227210177173132
Other undisclosed accounts payable and accrued liabilities866708811477175161260
Deferred revenue and credits   36
Other undisclosed current liabilities61649022721017717396
Total current liabilities:1,8741,4771,264897529506524
Noncurrent Liabilities
Long-term debt and lease obligation1,4551,570     
Operating lease, liability1,4551,570
Other undisclosed noncurrent liabilities(1,455)(1,570)     
Total noncurrent liabilities:1,4551,570     
Total liabilities:3,3293,0471,264897529506524
Stockholders' equity
Stockholders' equity attributable to parent11,14914,2133,9814,3264,4895,2205,601
Preferred stock2626     
Common stock942939774711681654605
Additional paid in capital35,28535,21422,83020,84419,55219,40018,327
Accumulated other comprehensive loss(43)(40)(37)(26)(16)(14)(12)
Accumulated deficit(25,060)(21,926)(19,587)(17,194)(15,728)(14,819)(13,319)
Stockholders' equity note, subscriptions receivable   (9) 
Total stockholders' equity:11,14914,2133,9814,3264,4895,2205,601
TOTAL LIABILITIES AND EQUITY:14,47817,2605,2455,2235,0185,7276,124

Income statement (P&L) ($ in thousands)

11/30/2020
TTM
5/31/2020
5/31/2019
5/31/2018
5/31/2017
5/31/2016
5/31/2015
Revenues6,4186,6935,2015,5645,7925,1404,962
Revenue, net 5,7925,1404,962
Cost of revenue(4,928)(4,911)(3,909)(3,810)(3,770)(3,616)(3,421)
Gross profit:1,4901,7821,2921,7542,0221,5241,542
Operating expenses(6,029)(4,185)(3,705)(3,236)(2,976)(2,351)(2,212)
Operating loss:(4,539)(2,403)(2,413)(1,482)(955)(827)(671)
Nonoperating income79714448463124
Investment income, nonoperating79714448462422
Other nonoperating income     72
Interest and debt expense(0)(0)(0)(0)(0)(0) 
Other undisclosed income from continuing operations before equity method investments, income taxes000000 
Loss from continuing operations before income taxes:(4,460)(2,332)(2,369)(1,434)(909)(796)(646)
Income tax expense (benefit)(15)(7)(24)(32) (704)315
Other undisclosed loss from continuing operations(7)      
Net loss:(4,482)(2,339)(2,393)(1,466)(909)(1,500)(331)
Other undisclosed net loss attributable to parent(0)      
Net loss available to common stockholders, diluted:(4,482)(2,339)(2,393)(1,466)(909)(1,500)(331)

Comprehensive Income ($ in thousands)

11/30/2020
TTM
5/31/2020
5/31/2019
5/31/2018
5/31/2017
5/31/2016
5/31/2015
Net loss:(4,482)(2,339)(2,393)(1,466)(909)(1,500)(331)
Other comprehensive income    2  
Comprehensive loss:(4,482)(2,339)(2,393)(1,466)(906)(1,500)(331)
Other undisclosed comprehensive loss, net of tax, attributable to parent(3)(3)(10)(10)(4)(1)(2)
Comprehensive loss, net of tax, attributable to parent:(4,485)(2,342)(2,403)(1,476)(911)(1,501)(334)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: